Hogan Lovells advised Perspective Therapeutics on the deal. Perspective Therapeutics (NYSE AMERICAN: CATX) has completed an underwritten offering of 51,515,880 shares of its common stock at...
Perspective Therapeutics’ $80 Million Shares Offering
Perspective Therapeutics’ $69 Million Shares Offering and $20.8 Million Private Placement
Hogan Lovells advised Perspective Therapeutics on a series of strategic transactions. Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX) has completed a series of strategic transactions with Lantheus Holdings (NASDAQ:...
OncoResponse’s $50 Million Senior Secured Term Loan
Hogan Lovells has advised OncoResponse on the deal. OncoResponse, a clinical-stage biotech company advancing immunotherapies for the treatment of cancer patients, closed a $50 million senior...